HK Stock Market Move | MINIEYE (02431) rises nearly 40%, receiving purchase orders for 200 unmanned logistics vehicles and recent designated head autonomous brand orders again.
Innovative Technology (02431) surged nearly 40% in the afternoon, up 28.61% as of press time, reaching 10.61 Hong Kong dollars, with a turnover of 4.12 billion Hong Kong dollars.
MINIEYE (02431) rose nearly 40% in the afternoon, with an increase of 28.61% to HK$10.61 at the time of writing, with a turnover of HK$4.12 billion.
In terms of news, MINIEYE has recently received a lot of positive news. On May 19th, the company announced the signing of a "Unmanned Logistics Vehicle Purchase and Long-term Cooperation Agreement" with Jiangsu Dan Yang High-tech Industrial Development Co., Ltd., finalizing the purchase order for 200 unmanned logistics vehicles. In this cooperation, MINIEYE will deliver a batch of MiniT5 Pro vehicles without maps, which is the first batch of orders received by the company after the release of the truly map-less unmanned vehicle. In addition, the company has recently won a new designated project from a leading domestic brand, providing integrated DMS (Driver Monitoring System) and OMS (Occupant Monitoring System) solutions for its flagship models both domestically and internationally, covering the domestic and EU markets, and plans to begin mass production in the third quarter of this year.
Softbank China stated that automobile companies are accelerating the layout of intelligent driving rights strategies, with existing clients of the company achieving more mid-to-high-end intelligent driving product designations, successfully expanding to new customers and commercializing the L4 business and continuing to deliver. The company will move into a new stage of double driving in L2+ and L4, with more significant performance elasticity expected. Caitong also indicated that the company's cockpit and driving synergy is significant, continuously gaining designation from customers both domestically and abroad; and with the mass delivery of L4 products, there is potential for new performance growth in the future.
Related Articles

New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.

New IPO news: Xiangdao Travel submitted a second application to the Hong Kong Stock Exchange, attracting key industry chain investors such as Momenta, Gaode, and Contemporary Amperex Technology.

New Stock News | Innovative biopharmaceutical company Sinocelltech Inc. (688520.SH) files for listing on the Hong Kong Stock Exchange with a gross profit margin of over 90% for three consecutive years.
New Stock News | Rongtai Pharmaceutical submits a second application to the Hong Kong Stock Exchange, becoming China's third-largest provider of digital marketing and supply chain services for the outpatient pharmaceutical market.

New IPO news: Xiangdao Travel submitted a second application to the Hong Kong Stock Exchange, attracting key industry chain investors such as Momenta, Gaode, and Contemporary Amperex Technology.

New Stock News | Innovative biopharmaceutical company Sinocelltech Inc. (688520.SH) files for listing on the Hong Kong Stock Exchange with a gross profit margin of over 90% for three consecutive years.






